Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Recurrent Prostate Cancer is a specialized medical facility dedicated to the advanced diagnosis and treatment of prostate cancer recurrence. Located in Marina del Rey, California, the center provides expert second opinions and personalized management strategies for patients who have failed primary treatments like surgery or radiation. Led by Dr. Mark Scholz, a pioneer in prostate medical oncology, the center utilizes cutting-edge technologies such as PSMA PET imaging to precisely locate and treat recurrent disease. Their multidisciplinary approach integrates hormone therapy, immunotherapy, and targeted radiation to optimize patient outcomes and quality of life. The center is a division of Prostate Oncology Specialists and is closely associated with the Prostate Cancer Research Institute, serving as a global destination for men seeking specialized care for rising PSA levels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Center for Recurrent Prostate Cancer.